Biora Therapeutics, Inc. (BIORQ) vs VivoSim Labs, Inc. (VIVS)

Biora Therapeutics, Inc. and VivoSim Labs, Inc. are both Biotechnology companies. Biora Therapeutics, Inc. and VivoSim Labs, Inc. are of similar size ($2.5M and $2.3M). Biora Therapeutics, Inc. grew revenue faster over the last twelve months: 347.0% against −21.1%. Biora Therapeutics, Inc. has the higher net margin (−3,527.9% vs −11,016.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Biora Therapeutics, Inc. leads on 10 and VivoSim Labs, Inc. on 5.

Valuation

Metric BIORQ VIVS Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6.55 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.08 0.66
EV/Sales 67.44 (8.35) 9.02
Earnings yield 0.00% (3,192.86%) (32.88%)
Free cash flow yield 0.00% (164.43%) (23.13%)

Profitability

Metric BIORQ VIVS Biotechnology median
Gross margin 85.79% 100.00% 68.51%
Operating margin (6,809.06%) (10,116.96%) 0.00%
Net margin (3,527.85%) (11,016.07%) 0.00%
Free cash flow margin (5,165.88%) (1,014.29%) 0.00%
Return on equity 27.98% (343.10%) (51.96%)
Return on assets (128.19%) (155.93%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BIORQ VIVS Biotechnology median
Revenue growth (TTM) 347.00% (21.13%) 6.76%
EPS growth (last fiscal year) (57.40%) (214.71%) 29.88%
Revenue growth, 5-year CAGR (87.44%) (43.10%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIORQ VIVS Biotechnology median
Debt to equity (0.18) 0.00 0.00
Current ratio 0.05 1.70 4.97
Net debt to EBITDA (0.47) 0.45 1.01

Dividend

Metric BIORQ VIVS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BIORQ VIVS Biotechnology median
Market cap 2.49m 2.34m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack